Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
120
Trial Sponsor
Clinical Trial Start Date
2005
0Primary Completion Date
2008
0Study Completion Date
2008
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Interventional Trial Phase
Phase 10
Official Name
A Phase I Dose-Escalation Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy0
Last Updated
June 8, 2011
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
Single0
Study summary
The purpose of this study is to evaluate the clinical and laboratory safety of SB-509 when given as a single treatment by an intramuscular injection to subjects with diabetic neuropathy.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
